Skip to main content
. 2022 Feb 21;13:826138. doi: 10.3389/fpsyt.2022.826138

Table 4.

Subgroup analyses of potential moderators.

Criterion (N treatments arms) Chi2 df p I 2
Baseline severity [Yes (16) vs. No (11)] 1.6 1 0.21 37.4%
Dose design [Fixed (18) vs. Flexible (9)] 5.68 1 0.02 82.4%
Lower concentrations included [Yes (20) vs. No (7)] 3.74 1 0.05 73.3%
TCA subsample
Dose design [Fixed (12) vs. Flexible (4)] 6.09 1 0.01 83.6%
Lower concentrations included [Yes (12) vs. No (4)] 0.53 1 0.47 0%
SSRI subsample
Dose design [Fixed (3) vs. Flexible (4)] 0.46 1 0.50 0%
Lower concentrations included [Yes (4) vs. No (3)] 3.87 1 0.05 74.2%